Revolutionizing the treatment of chronic pain patients. Through the use of innovative technology, we offer a treatment which focuses on the individual patient’s health and needs.


REDO - Neurosystems' goal is to create tomorrow's pain alleviation treatment for patients suffering from chronic muscle- and joint pain. Our innovative treatment is founded on patient centered care which puts the individual patient’s health and needs into focus.


The vision is to lead the field of treatment of chronic muscle- and joint pain. Our advanced neurotechnology offers the possibility of a drug-free treatment, which is 100 % based on mental and physical rehabilitation. In REDO, we strive to supply a more effective and sustainable treatment to combat chronic pain, in order to increase the patients quality of life.

Quality of life

Our aim is to ensure a healthy lifestyle for chronic pain patients. At REDO we do this through self-taught manipulation of pain-related brain activity. We want to develop a treatment that focuses on improving the health and well-being of our patients - now and in the future.


Innovative Growth

We started our entrepreneurial adventure in the summer of 2019 on Innovative Growth, which is a startup program for entrepreneurs in Aalborg.

Micro Grant

In December 2019 we received the Life Science Grant from The Danish Foundation for Entrepreneurship and the Bristol-Myers Squibb.


From September 2020 and a year onwards we were funded by The Innovation Fund Denmark. We participated in their prestigious Innofounder Gradute Program.


In 2021 we were accepted into the Beyond Beta accelerator program and we got an investment from Accelerace and Vaekstfonden on €270.000

EY Entrepreneur Of The Year, 2021

Nominated as one of the three finalists in the Start-up/Scaleup category.


We received the Innobooster grant to further improve our software, RELEARN.


We are a part of the Newchip accelerator. The accelerator provide us with tools and skills to fund, build and scale.


In collaboration with the Regional Hospital, Center for Clinical Research, we are during our last clinical trial before getting our medical CE-certificate.

Commercial pilot

We are granted a Life Science Grant with an aim to commercialize RELEARN and the main goal in the program is to run a commercial pilot in collaboration with 'Aalborg Smerte- og Sportsklinik'.
    We've Raised
    As of Today